Patrice is Co-Chair of Fox Rothschild’s national Medical Technology practice group.

She advises medical technology companies and other emerging businesses, and venture capital and strategic investors in a broad range of commercial and financing matters, including:

• venture capital financings
• private placements
• mergers and acquisitions
• venture debt and credit facilities
• securities compliance

Patrice also guides lenders in commercial loan transactions, including $100 million+ loan facilities, and advises clients on equity financing structures and clinical trial agreements.

She frequently counsels boards of directors on fiduciary duties and corporate governance obligations.

Recent Transactions

• Advised Nuvaira, Inc. in securing $80 million in Series E financing
• Counsel for Aria CV in $28 million Series B financing
• U.S. Counsel for Imricor Medical Systems, Inc. in its listing on the Australian Securities Exchange (ASX)
• Represented Abilitech Medical in securing $8 million in preferred stock financings
• Advised strategic investors Allianz Life and Educational Credit Management Company in numerous venture capital investments

Representative Clients

Patrice has represented numerous investors in venture capital financings, including Vensana Capital, Split Rock Partners, Educational Credit Management Corporation, Allianz Life Ventures and Technology Venture Partners.

Her clients in venture capital financings and private financings include Nuvaira, Inc.; Aria CV, Inc., Imricor Medical Systems, Inc., Spineology Inc., Abilitech Medical, Inc., Oculogica Inc. and Cardionomic, Inc.

In farm credit matters, Patrice has represented Farm Credit Services of Western Arkansas, AgCountry CFG, ProPartners Financial and AgCountry Farm Credit Services.